Structure based design and synthesis of 3-(7-nitro-3-oxo-3,4-dihydroquinoxalin-2-yl)propanehydrazide derivatives as novel bacterial DNA-gyrase inhibitors: In-vitro, In-vivo, In-silico and SAR studies
- 5 October 2022
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 129, 106186
Abstract
No abstract availableKeywords
Funding Information
- Al-Azhar University
This publication has 87 references indexed in Scilit:
- Molecular Docking and Prediction of Pharmacokinetic Properties of Dual Mechanism Drugs that Block MAO-B and Adenosine A2A Receptors for the Treatment of Parkinson's DiseaseJournal of Young Pharmacists, 2012
- Hepatic safety of antibiotics used in primary careJournal of Antimicrobial Chemotherapy, 2011
- Quinolone-Mediated Bacterial DeathAntimicrobial Agents and Chemotherapy, 2008
- Clinical chemistry and haematology historical data in control Sprague-Dawley rats from pre-clinical toxicity studiesExperimental and Toxicologic Pathology, 2006
- Tolerance of Pseudomonas aeruginosa to Melaleuca alternifolia (tea tree) oil is associated with the outer membrane and energy-dependent cellular processesJournal of Antimicrobial Chemotherapy, 2004
- ESOL: Estimating Aqueous Solubility Directly from Molecular StructureJournal of Chemical Information and Computer Sciences, 2004
- Molecular Properties That Influence the Oral Bioavailability of Drug CandidatesJournal of Medicinal Chemistry, 2002
- Pharmacodynamics of Telithromycin In Vitro against Respiratory Tract PathogensAntimicrobial Agents and Chemotherapy, 2001
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 1997
- The Nephrotoxicity of Antimicrobial AgentsNew England Journal of Medicine, 1977